Literature DB >> 26095782

PD-L1 expression by circulating breast cancer cells.

Rachel David.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26095782     DOI： 10.1016/S1470-2045(15)00074-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

Review 1.  The promise of circulating tumor cells for precision cancer therapy.

Authors:  William L Hwang; Katie L Hwang; David T Miyamoto
Journal:  Biomark Med       Date:  2016-12-07       Impact factor: 2.851

Review 2.  Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.

Authors:  Malte Mohme; Sabine Riethdorf; Klaus Pantel
Journal:  Nat Rev Clin Oncol       Date:  2016-09-20       Impact factor: 66.675

Review 3.  Functional studies on circulating and disseminated tumor cells in carcinoma patients.

Authors:  Catherine Alix-Panabières; Kai Bartkowiak; Klaus Pantel
Journal:  Mol Oncol       Date:  2016-01-18       Impact factor: 6.603

4.  Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer.

Authors:  Christophe Glorieux; Xiaojun Xia; Xin You; Zining Wang; Yi Han; Jing Yang; Gauthier Noppe; Christophe de Meester; Jianhua Ling; Annie Robert; Hui Zhang; Sheng-Ping Li; Huamin Wang; Paul J Chiao; Li Zhang; Xiaobing Li; Peng Huang
Journal:  J Adv Res       Date:  2021-12-21       Impact factor: 12.822

Review 5.  Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer.

Authors:  Hongyi Zhang; Xiaoyan Lin; Yuan Huang; Minghong Wang; Chunmei Cen; Shasha Tang; Marcia R Dique; Lu Cai; Manuel A Luis; Jillian Smollar; Yuan Wan; Fengfeng Cai
Journal:  Front Oncol       Date:  2021-06-02       Impact factor: 6.244

Review 6.  Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Authors:  Matthias Preusser; Anna S Berghoff; Wolfgang Wick; Michael Weller
Journal:  Clin Neuropathol       Date:  2015 Nov-Dec       Impact factor: 1.368

Review 7.  Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.

Authors:  Hongxia Wang; Nikolas H Stoecklein; Peter P Lin; Olivier Gires
Journal:  Oncotarget       Date:  2017-01-03

8.  Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer.

Authors:  Masahiko Amatatsu; Takaaki Arigami; Yoshikazu Uenosono; Shigehiro Yanagita; Yasuto Uchikado; Yuko Kijima; Hiroshi Kurahara; Yoshiaki Kita; Shinichiro Mori; Ken Sasaki; Itaru Omoto; Kosei Maemura; Sumiya Ishigami; Shoji Natsugoe
Journal:  Cancer Sci       Date:  2018-02-19       Impact factor: 6.716

Review 9.  Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model.

Authors:  Chang Yang; Bai-Rong Xia; Wei-Lin Jin; Ge Lou
Journal:  Cancer Cell Int       Date:  2019-12-18       Impact factor: 5.722
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.